Insider Shareholders with Direct Ownership of Rocket Pharmaceuticals, Inc. (RCKT)
This section provides a comprehensive overview of the insiders with direct ownership of Rocket Pharmaceuticals, Inc. (RCKT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ROCKET PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gaurav Shah
CEO |
391,457 | 351,870 | 786,806 $2.27 Million | 25 |
May 20, 2025
Reduced 0.29%
|
| 335,929 | 47,634 | 441,927 $1.27 Million | 21 |
May 20, 2025
Reduced 0.17%
|
|
| 304,847 | 66,033 | 235,255 $677,534 | 10 |
May 20, 2025
Reduced 0.34%
|
|
|
Martin Wilson
General Counsel |
155,132 | 25,393 | 149,163 $429,589 | 14 |
May 20, 2025
Reduced 0.39%
|
|
Aaron Ondrey
Chief Financial Officer |
137,139 | 7,489 | 129,650 $373,392 | 3 |
Apr 04, 2025
Reduced 5.46%
|
| 99,624 | 193,124 | 114,784 $330,577 | 5 |
Apr 15, 2024
Reduced 8.01%
|
|
| 87,758 | 18,638 | 69,140 $199,123 | 5 |
Oct 31, 2024
Reduced 4.26%
|
|
| 92,599 | 32,910 | 64,027 $184,397 | 35 |
May 20, 2025
Reduced 0.55%
|
|
| 14,220 | 0 | 14,220 $40,953 | 1 |
Mar 05, 2025
Added 50.0%
|